Skip to content

Fostering Innovations in Nutritional and Omics-driven Diabetes Care, FIND

Precision Subtyping of Diabetes Based on Omics: Identification and Evaluation of Biomarkers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127617
Enrollment
Unknown
Registered
2026-07-03
Start date
2024-12-04
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Sponsors

The General Hospital of Western Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with type 2 diabetes based on Chinese diagnostic criteria, those with diagnosis made within 2 years prior to enrollment will be recruited in priority; 2. Adults aged 18-70 years old; 3. No diabetes complications such as diabetic nephropathy, diabetic retinopathy, etc; 4. HbA1c <=12%; 5. Willingness to participate and sign informed consent form;

Exclusion criteria

Exclusion criteria: 1.Diagnosed with type 1 diabetes; 2.Currently undergoing insulin therapy; 3.Severe metabolic diseases, digestive system diseases, or psychiatric disorders;

Design outcomes

Primary

MeasureTime frame
Incidence of Diabetic Nephropathy;

Secondary

MeasureTime frame
Proteomics;Gut microbiome;Metabolomics;

Countries

China

Contacts

Public ContactLin Ning

The General Hospital of Western Theater Command

helenmedic@yeah.net+86 28 86570983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026